← All organizations

EndoCeutics Inc.

For profitContributed to NMEWebsite ↗

Also known as: EndoCeutics Inc. | Endoceutics, Inc., Quebec, Canada

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Jul 31, 2019

Timeline

2000s

Jul 1, 2006
EndoCeutics Inc.— Founded

2010s

Nov 16, 2016
prasterone— NDA Organization

Drugs by trial phase (4 distinct, 10 trials)

Phase 3 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

prasterone

Recent trials (15)

NCT03740945Study chairPhase 3Jul 31, 2019
NCT03740945Lead sponsorPhase 3Jul 31, 2019
NCT03782480CollaboratorPhase 3Mar 2, 2019
NCT03782480Study directorPhase 3Mar 2, 2019
NCT03619005Study chairPhase 3Sep 30, 2018
NCT03619005Lead sponsorPhase 3Sep 30, 2018
NCT03287232Study chairPhase 3Oct 16, 2017
NCT03287232Lead sponsorPhase 3Oct 16, 2017
NCT02013544Lead sponsorPhase 3Feb 1, 2014
NCT02013544Study chairPhase 3Feb 1, 2014
NCT01452373Lead sponsorPhase 3Oct 1, 2011
NCT01358760Lead sponsorPhase 3Jun 1, 2011
NCT01256671Lead sponsorPhase 3Dec 1, 2010
NCT01256684Lead sponsorPhase 3Dec 1, 2010
NCT01846442Lead sponsorPhase 3Jun 1, 2007

Details

Founded: Quebec, Quebec, CA Jul 1, 2006
First NDA: Nov 16, 2016
Last known activity: Jul 31, 2019